ARCHIVES

Women’s Health: Treatment to Move Toward Pre-Cancer, Klausner Says

This article is from The Cancer Letter archive.

Vol. 23 No. 46 | December 5, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014